Personal tools

Coexpression cluster:C1496: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
(Created page with "{{Coexpression_clusters |full_id=C1496_Fibroblast_Smooth_papillotubular_basal_liposarcoma_tenocyte_mesenchymal |id=C1496 }}")
 
No edit summary
Line 2: Line 2:
|full_id=C1496_Fibroblast_Smooth_papillotubular_basal_liposarcoma_tenocyte_mesenchymal
|full_id=C1496_Fibroblast_Smooth_papillotubular_basal_liposarcoma_tenocyte_mesenchymal
|id=C1496
|id=C1496
|ontology_enrichment_celltype=CL:0000055!1.25e-27!180;CL:0000057!2.71e-16!75;CL:0000680!3.02e-14!57;CL:0000056!3.02e-14!57;CL:0000355!3.02e-14!57;CL:0000192!6.19e-13!42;CL:0000514!6.19e-13!42;CL:0000187!6.65e-13!54;CL:0000359!7.53e-12!32;CL:0000393!3.68e-11!60;CL:0000211!3.68e-11!60;CL:0000183!6.72e-11!59;CL:0002620!2.11e-10!23
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0000914!1.85e-18!83;UBERON:0002329!1.85e-18!83;UBERON:0003077!1.85e-18!83;UBERON:0003059!1.85e-18!83;UBERON:0007282!1.85e-18!83;UBERON:0009618!1.85e-18!83;UBERON:0007285!1.85e-18!83;UBERON:0000486!9.64e-16!82;UBERON:0003102!2.03e-15!95;UBERON:0000475!5.63e-15!365;UBERON:0004290!7.09e-14!70;UBERON:0001134!2.07e-13!61;UBERON:0002036!2.07e-13!61;UBERON:0003082!2.07e-13!61;UBERON:0002385!3.07e-13!63;UBERON:0001015!3.07e-13!63;UBERON:0000383!3.07e-13!63;UBERON:0000481!1.12e-11!347;UBERON:0005256!3.39e-10!143;UBERON:0002199!1.99e-09!45;UBERON:0002416!1.99e-09!45;UBERON:0003104!4.14e-09!238;UBERON:0009142!4.14e-09!238;UBERON:0002100!5.25e-09!216;UBERON:0002097!1.29e-08!40;UBERON:0000165!5.34e-07!28;UBERON:0000930!5.34e-07!28;UBERON:0001444!6.10e-07!48
}}
}}

Revision as of 14:12, 21 May 2012


Full id: C1496_Fibroblast_Smooth_papillotubular_basal_liposarcoma_tenocyte_mesenchymal



Phase1 CAGE Peaks

Hg19::chr2:158114174..158114187,+p6@GALNT5
Hg19::chr2:158114199..158114286,+p1@GALNT5
Hg19::chr2:158114415..158114429,+p7@GALNT5
Hg19::chr2:158114442..158114458,+p5@GALNT5
Hg19::chr2:158114478..158114500,+p3@GALNT5
Hg19::chr2:158114516..158114531,+p4@GALNT5


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


No GOStat results

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
somite1.85e-1883
paraxial mesoderm1.85e-1883
presomitic mesoderm1.85e-1883
presumptive segmental plate1.85e-1883
trunk paraxial mesoderm1.85e-1883
presumptive paraxial mesoderm1.85e-1883
multilaminar epithelium9.64e-1682
surface structure2.03e-1595
organism subdivision5.63e-15365
dermomyotome7.09e-1470
skeletal muscle tissue2.07e-1361
striated muscle tissue2.07e-1361
myotome2.07e-1361
muscle tissue3.07e-1363
musculature3.07e-1363
musculature of body3.07e-1363
multi-tissue structure1.12e-11347
trunk mesenchyme3.39e-10143
integument1.99e-0945
integumental system1.99e-0945
mesenchyme4.14e-09238
entire embryonic mesenchyme4.14e-09238
trunk5.25e-09216
skin of body1.29e-0840
mouth5.34e-0728
stomodeum5.34e-0728
subdivision of head6.10e-0748


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.